Please Wait
Applying Filters...
menu
    • menu
    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Taliglucerase Alfa

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pfizer's Biologic Elelyso (Taliglucerase Alfa) Receives Suppl Approvals in US
    Pfizer's Biologic Elelyso (Taliglucerase Alfa) Receives Suppl Approvals in US

    10 Jul 2024

    // Taliglucerase Alfa -- PB000469 FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022458

    Taliglucerase Alfa -- PB000469 FDA
    10 Jul 2024
    Share Share
    Pfizer's Biologic Elelyso (Taliglucerase Alfa) Receives Approval in the U.S.
    Pfizer's Biologic Elelyso (Taliglucerase Alfa) Receives Approval in the U.S.

    09 May 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022458

    FDA
    09 May 2023
    Share Share
    Pfizer's Biologic Elelyso (Taliglucerase Alfa) Receives Approval in the U.S.
    Pfizer's Biologic Elelyso (Taliglucerase Alfa) Receives Approval in the U.S.

    30 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022458

    FDA
    30 Aug 2022
    Share Share
    Pfizer`s Elelyso (Taliglucerase Alfa) Receives Supplemental Approval In U.S
    Pfizer`s Elelyso (Taliglucerase Alfa) Receives Supplemental Approval In U.S

    06 Nov 2020

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022458

    FDA
    06 Nov 2020
    Share Share
    Enforcement Report - Week of March 11, 2020
    Enforcement Report - Week of March 11, 2020

    12 Mar 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-11-2020-1583989701.pdf

    FDA
    12 Mar 2020
    Share Share
    Enforcement Report - Week of October 10, 2018
    Enforcement Report - Week of October 10, 2018

    10 Oct 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=910201811531

    FDA
    10 Oct 2018
    Share Share